Net profit of Alembic Pharmaceuticals rose 14.60% to Rs 154.38 crore in the quarter ended June 2025 as against Rs 134.71 crore during the previous quarter ended June 2024. Sales rose 9.54% to Rs 1710.72 crore in the quarter ended June 2025 as against Rs 1561.73 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 1710.72 | 1561.73 | 10 |
OPM % | 16.42 | 15.16 | - |
PBDT | 263.88 | 226.07 | 17 |
PBT | 190.11 | 157.03 | 21 |
NP | 154.38 | 134.71 | 15 |